Home › Free Stock Grades › RMD
ResMed Inc. (RMD) Stock Grade
RMD · Healthcare
A+
Market Cap
$32.6B
P/E Ratio
18.5
Revenue Growth (YoY)
+9.9%
Net Margin
26.9%
Return on Equity
23.1%
Dividend Yield
2.2%
About ResMed Inc.'s fundamentals
ResMed is a large-cap medical device company with a $37.9 billion market valuation that generated 9.8% year-over-year revenue growth. The company demonstrates strong operational efficiency with a net margin of 27.2% and returns 23.5% on shareholder equity, indicating effective capital management. At a P/E ratio of 27.0, the valuation reflects investor expectations for continued performance, while the company returns a modest 0.9% dividend yield to shareholders.